Core Viewpoint - The company conducted a self-examination regarding the trading activities of insiders and incentive recipients related to the 2025 restricted stock incentive plan, confirming no insider trading occurred during the specified period [1][4]. Group 1: Examination Process - The company held meetings on July 15, 2025, to approve the draft of the 2025 restricted stock incentive plan and implemented necessary confidentiality measures [1]. - The self-examination period was defined as January 17, 2025, to July 16, 2025, during which the trading activities of insiders were scrutinized [2]. Group 2: Trading Activities of Insiders - Two incentive recipients traded company stock after being aware of the incentive plan but claimed their actions were based on market conditions, not insider information [2]. - Four additional individuals, including three incentive recipients, traded company stock before being informed of the incentive plan, and they also confirmed their trades were based on market conditions [3]. Group 3: Conclusion of the Examination - The company adhered to relevant regulations and internal confidentiality protocols, ensuring that no insider information was leaked prior to the public announcement of the incentive plan [3][4]. - The examination concluded that all individuals involved did not engage in insider trading or leak insider information related to the incentive plan [4].

广东因赛品牌营销集团股份有限公司 一、本次激励计划首次授予的分配情况 获授的限制 占首次授予限 占本次激励计划 姓名 国籍 职务 性股票数量 制性股票总数 预留授予时公司 （万股） 的比例 股本总额的比例 副总经理、董事 张达霖 中国 1.7880 7.3171% 0.0109% 会秘书 中层管理人员、核心技术（业务）骨干 （合计 22 人） 合计 24.4360 100.00% 0.1491% 注：1、上述任何一名激励对象通过全部有效期内的股权激励计划获授的本公司股票累计均未超过本 次 激励计划草案公告时公司股本总额的 1%。公司全部在有效期内的股权激励计划所涉及的标的股票总数 累计 未超过本次激励计划草案公告时公司股本总额的 20%。 的股东或实际控制人及其配偶、父母、子女。 二、预留授予的中层管理人员、核心技术（业务）骨干（合计 22 人）名单 序号 姓名 类别 广东因赛品牌营销集团股份有限公司董事会 序号 姓名 类别 ...

内蒙古加度律师事务所 关于 中盐内蒙古化工股份有限公司 关于 2021 年限制性股票激励计划预留授予限制性 股票第二个解除限售期解除限售条件成就 之 法律意见书 地址：内蒙古包头市稀土高新区时代广场 B 座 1410 电话：0472-7159669 传真：0472-7159669 邮编：014060 内蒙古加度律师事务所 关于中盐内蒙古化工股份有限公司 第二个解除限售期解除限售条件成就之法律意见书 致：中盐内蒙古化工股份有限公司 内蒙古加度律师事务所（以下简称"本所"）接受中盐内蒙古化工股份有限 公司（以下简称"中盐化工"或"公司"）的委托，并根据中盐化工与本所签订 的《专项法律服务合同》，作为中盐化工 2021 年限制性股票激励计划（以下简 称"本次股权激励计划"或"本激励计划"）的相关事宜的专项法律顾问。本法律意 见书系依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》 （以下简称"《管理办法》"）、《国有控股上市公司（境内）实施股权激励试 行办法》（以下简称"《试行办法》"）、《关于规范国有控股上市公司实施股 权激励 ...

Group 1 - The core viewpoint of the news is the approval of the 2025 restricted stock incentive plan by the Compensation and Assessment Committee of Nanjing Gaohua Technology Co., Ltd, which includes a list of eligible recipients and the grant price [1][2] - The incentive plan excludes independent directors, shareholders holding 5% or more of the company's shares, and the actual controller along with their immediate family members [2] - The grant date for the incentive plan is set for August 1, 2025, with a grant price of 13.26 yuan per share [2] Group 2 - The Compensation and Assessment Committee conducted a review based on various legal and regulatory frameworks, ensuring that the recipients meet the qualifications outlined in the company's articles of association [1] - Specific disqualifications for recipients include being identified as inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months, or having been subject to administrative penalties or market entry bans due to significant violations [1] - The committee's review confirms that the incentive plan adheres to the conditions set forth in the draft plan, ensuring compliance with relevant laws and regulations [2]

Core Points - The announcement details the results of the third vesting period of the 2022 restricted stock incentive plan of Hengxuan Technology, with a total of 428,852 shares being vested and set to be listed on August 6, 2025 [1][10] - The shares are sourced from the company's issuance of A-share common stock to incentive recipients [5] Summary by Sections Incentive Plan Overview - The board of directors approved the incentive plan on April 25, 2022, and independent directors provided their opinions on the related proposals [2] - The supervisory board verified the incentive plan and issued relevant opinions [2][3] Vesting Details - A total of 150 incentive recipients will receive the vested shares, which include both technical and business personnel [5] - The total number of shares vested is 428,852, which represents approximately 30% of the total shares granted [5][10] Stock Listing and Capital Changes - The listing date for the vested shares is set for August 6, 2025, with a total of 428,852 shares to be listed [5] - The company's total share capital will increase from 167,937,371 shares to 168,366,223 shares following this vesting [8] Financial Impact - For the first quarter of 2025, the company reported a net profit attributable to shareholders of 191 million yuan, with basic earnings per share of 1.59 yuan [9] - The dilution effect on earnings per share will occur due to the increase in total share capital following the vesting [9]

Core Viewpoint - The announcement details the results of the second vesting period of the 2021 Restricted Stock Incentive Plan for Nanjing University Environmental Planning and Design Institute Group Co., Ltd, confirming that the vesting conditions have been met and shares will be listed [1][19]. Summary by Sections Incentive Plan Overview - The 2021 Restricted Stock Incentive Plan was approved in meetings held on March 7, 2022, and May 27, 2022, with a total of 235 individuals eligible for the incentive, primarily core technical personnel impacting the company's performance [1][2]. Allocation of Restricted Stocks - A total of 273.60 million shares were allocated under the incentive plan, with 243.90 million shares (89.14%) granted to core technical personnel and 29.70 million shares (10.86%) reserved [2]. Vesting Conditions - The vesting of restricted stocks occurs in three phases, with the second vesting period defined as the first trading day after 36 months from the grant date until 48 months [3][4]. - The vesting conditions include company performance metrics and individual performance assessments, with specific targets set for each vesting period [5][6]. Performance Assessment - The performance assessment for the first vesting period requires a net asset return of at least 10% and performance above the 75th percentile of industry peers [5][23]. - The company achieved a revenue growth rate of 13.64% in 2023, surpassing the required benchmarks [23]. Vesting Results - For the second vesting period, 127.217 million shares will vest for 195 individuals at a price of 12.43 yuan per share, representing 33.07% of the total shares granted [19][24]. - The shares will be listed for trading on August 5, 2025, and the total number of shares will increase from 15,648.8669 million to 15,776.0839 million [24][25]. Legal and Compliance - The company has complied with all necessary legal requirements and received the appropriate approvals for the adjustments and vesting of shares, ensuring no detriment to shareholder interests [26]. Financial Impact - The issuance of these shares is expected to have a minimal impact on the company's financial status and performance metrics, with the new shares diluting earnings per share and net asset return [25].

证券代码：600328 证券简称：中盐化工 公告编号：2025-075 中盐内蒙古化工股份有限公司 关于 2021 年限制性股票激励计划预留授予限制性股票 第二个解除限售期解除限售暨上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为股权激励股份；股票认购方式为网下，上 市股数为920,556股。 本次股票上市流通总数为920,556股。 ? 本次股票上市流通日期为2025 年 8 月 11 日。 中盐内蒙古化工股份有限公司（以下简称"公司"）于 2025 年 年限制性股票激励计划预留授予部分第二个解除限售期解除限售条 件成就的议案》。根据《中盐内蒙古化工股份有限公司 2021 年限制 性股票激励计划（草案修订稿）》（以下简称"《激励计划（草案修 订稿）》"）的规定和公司 2022 年第一次临时股东大会的授权，现就 公司 2021 年限制性股票激励计划预留授予部分第二个解除限售期 解除限售条件成就的相关情况说明如下： 一、2021 年股权激励计划已履行的相关程序 第七届监事 ...

Core Viewpoint - The announcement details the results of the second vesting period of the 2023 restricted stock incentive plan for Shanghai Haoyuan Pharmaceutical Co., Ltd, including the number of shares to be listed and the relevant procedures for vesting and stock issuance [1][2][3]. Group 1: Stock Listing and Vesting Details - The total number of shares to be listed for trading is 527,660 shares, with the listing date set for August 6, 2025 [1][12]. - The second vesting period for the restricted stock was completed on July 31, 2025, and the company has received the necessary registration proof from the Shanghai branch of China Securities Depository and Clearing Corporation [1][11]. - The total number of shares vested in this period is 52.7660 million shares, which represents 50% of the total granted shares [8]. Group 2: Decision-Making Process - The decision-making process for the vesting involved multiple meetings, including the board of directors and the supervisory board, which approved the relevant proposals regarding the incentive plan [2][4]. - The independent directors provided their consent to the proposals related to the 2023 incentive plan [2][4]. - The company conducted an internal public notice regarding the list of proposed incentive recipients, with no objections received during the notice period [3]. Group 3: Financial Impact and Share Capital Changes - Following the vesting, the total share capital of the company increased from 211,571,033 shares to 212,098,693 shares [9][11]. - The company reported a net profit attributable to shareholders of 62,384,400.02 yuan for the first quarter of 2025, with basic earnings per share of 0.30 yuan per share [11]. - The new shares will dilute the earnings per share based on the increased total share capital while keeping the net profit unchanged [11].

Core Viewpoint - The company has approved the 2025 Restricted Stock Incentive Plan and has publicly disclosed the list of initial grant recipients, following the relevant regulations and guidelines [1][2]. Disclosure and Verification - The initial grant recipient list was publicly announced on July 23, 2025, and was open for feedback for a period of 10 days, during which no objections were received [2]. - The Compensation and Assessment Committee verified the eligibility of the initial grant recipients based on their employment contracts, identification documents, and their positions within the company [2]. Committee's Verification Opinion - The Compensation and Assessment Committee confirmed that all selected recipients meet the qualifications set forth in the relevant regulations and do not fall under any disqualifying conditions [3]. - The recipients do not include independent directors, foreign employees, or shareholders holding more than 5% of the company's shares, ensuring compliance with the incentive plan's objectives [3].

证券代码：301108 证券简称：洁雅股份 公告编号：2025-059 铜陵洁雅生物科技股份有限公司董事会薪酬与考核委员会 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 21 日召开第六届董事会第二次会议审议通过了《关于〈铜陵洁雅生物科技股份有限 公司 2025 年限制性股票激励计划（草案）〉及其摘要》《关于〈铜陵洁雅生物 科技股份有限公司 2025 年限制性股票激励计划实施考核管理办法〉的议案》等 相 关 议 案 ， 具 体 内 容 详 见 公 司 于 2025 年 7 月 22 日 披 露 于 巨 潮 资 讯 网 （www.cninfo.com.cn）的相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《深 圳证券交易所创业板股票上市规则》《深圳证券交易所创业板上市公司自律监管 指南第 1 号——业务办理》（以下简称"《自律监管指南》"）及《公司章程》 等相关规定，公司对 2025 年限制性股票激励计划（以下简称"本次激励计划"） 首次授予激励对象的姓名和职务在公司内部进行了公示。公司董事会薪酬与考核 委员会结合公示情况对激励对象进行了核查，相关公示情况 ...